Decision Making in Proliferative Diabetic Retinopathy Treatment

被引:0
作者
Mary B. Kansora
Raquel Goldhardt
机构
[1] VA North Texas Health Care System,Department of Ophthalmology
[2] The University of Texas Southwestern Medical Center,Surgical Services
[3] Miami Veterans Administration Medical Center,Bascom Palmer Eye Institute, Department of Ophthalmology
[4] University of Miami,undefined
来源
Current Ophthalmology Reports | 2019年 / 7卷
关键词
Proliferative diabetic retinopathy; Vascular endothelial growth factor; Anti-VEGF; Pan retinal photocoagulation; Intravitreal injection; Ranibizumab; Bevacizumab; Aflibercept;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:45 / 50
页数:5
相关论文
共 139 条
[1]  
Lee R(2015)Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss Eye Vis 2 17-600
[2]  
Wong T(1981)Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8 Ophthalmology 88 583-1239
[3]  
Sabanayagam C(2012)Diabetic retinopathy N Engl J Med 366 1227-538
[4]  
Antonetti DA(1963)Studies of the retinal capillaries in relation to diabetic and other retinopathies Br J Ophthalmol 47 521-300
[5]  
Klein R(1963)Capillary shunts in the pathogenesis of diabetic retinopathy Diabetes 12 293-378
[6]  
Gardner TW(1961)Retinal vascular patterns. IV. Diabetic retinopathy Arch. Ophthalmol 66 366-1046
[7]  
Ashton N(2010)Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovacular proliferation Clin Ophthalmol 4 1043-10
[8]  
Cogan DG(2013)Diabetic retinopathy and VEGF Open Ophthalmol J 7 4-986
[9]  
Kuwabara T(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-713
[10]  
Cogan DG(1998)Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 Br Med J 317 703-396